HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Delta agent hepatitis.

Abstract
Since its chance discovery a mere decade ago, the delta agent has been characterized as a novel pathogen that poses the risk of developing into a scourge of modern times. With its unique single-stranded circular RNA, exclusive dependence on HBV for its replication, and characteristic ability to suppress hepatitis B synthesis, the delta agent has emerged as an important global cause of fulminant hepatitis and progressive liver disease. Persons at greatest risk of delta infection are those living in endemic areas and HBsAg-carrier parenteral drug abusers, hemophiliacs, hemodialysis patients, and homosexual men in nonendemic areas. Widespread dissemination appears possible. There is as yet no known effective treatment for established delta infection, and, for the present, clinicians must concentrate on preventing HDV infection by incorporating vigorous use of the hepatitis B vaccine into strategies for preventing HBV infection.
AuthorsM Chatzinoff, L S Friedman
JournalInfectious disease clinics of North America (Infect Dis Clin North Am) Vol. 1 Issue 3 Pg. 529-45 (Sep 1987) ISSN: 0891-5520 [Print] United States
PMID3332883 (Publication Type: Journal Article, Review)
Topics
  • Hepatitis D (diagnosis, etiology, therapy)
  • Hepatitis Delta Virus (genetics, isolation & purification)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: